24th United European Gastroenterology Week, Vienna, Austria
15 - 19 October 2016
Research Partnership is delighted to be attending the United European Gastroenterology Week in Vienna next month. Now in its 24th year, UEG Week attracts around 14,000 participants from around the world.
Reviewing “real-world” patient cases to better understand disease remission in CD and the management of relapses
Following a poster presentation at the gastroenterology conference, UEG Week, Laurent Chanroux shares results from a study based on real-world patient cases to better understand disease remission in Crohn’s disease (CD) and the management of relapses.
Crohn's disease (CD) is a chronic inflammatory bowel disorder with a relapsing and remitting course and no known cure. The introduction of biologic therapy a decade ago has offered a new option for patients failing conventional therapy. However, clinical data suggests that although biologic agents have improved the outlook for many patients with moderate to severe CD, patients may still not be attaining remission. To help physicians manage their patients and achieve short and long-term goals with these new agents, it is important to review how these therapies may be optimised to ensure the best results.